ClinicalTrials.Veeva

Menu
N

NC Eye Associates | Apex, NC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

YP-P10
AZR-MD-001
Dupilumab
TP-03

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 4 total trials

A Phase 3 Study to Evaluate AZR-MD-001 in Patients With Abnormal Meibomian Gland Function and Dry Eye Disease (DED)

This study is a multicenter, double-masked, vehicle-controlled, randomized, parallel group study designed to evaluate the treatment of abnormal meibo...

Enrolling
Dry Eye Disease
Other: Vehicle
Drug: AZR-MD-001

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the effica...

Enrolling
Atopic Keratoconjunctivitis
Drug: Dupilumab

The objective of this study is to compare the safety and efficacy of YP-P10 Ophthalmic Solution to placebo for the treatment of the signs and symptom...

Active, not recruiting
Dry Eye
Drug: 1% YP-P10 Ophthalmic Solution
Drug: 0.3% YP-P10 Ophthalmic Solution

Trial sponsors

A
A
Tarsus Pharmaceuticals logo
Y

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems